Detroit-based cannabis company Common Citizen says it will be opening a manufacturing and R&D headquarters in Marshall later this summer as well as retail sales facilities in Flint, Lansing, Battle Creek, Hazel Park, and Detroit.
The Marshall facility will have a scale capacity of up to 1.2 million square feet and could create as many as 400 jobs over the next five years.
In the new, 5,000-square-foot retail operations, a Citizen advisor will guide medical cannabis customers through the product selection process, ensuring that needs are appropriately paired with that patient’s ideal formulations and delivery mechanism.
“We recognized that the people of Michigan and across the United States – our common citizens – deserve access to safe, quality cannabis,” says Michael Elias, CEO of Common Citizen. “Through a commitment to operational excellence and patient safety, we’re offering a wide range of human-centered cannabis products and experiences that will keep customer well-being at its core.”
The company’s focus on patient safety is reflected in its plans for the Marshall facility, which will have a state-of-the-art lab run by Dr. John Pierce, Common Citizen’s chief chemist and a pioneer in cannabis research.
The headquarters also will include a controlled environment agriculture greenhouse, where each strain and derivative product will be cultivated and then processed in-house.
“It’s always been about putting patients first,” says Elias. “If people are secondary to the product, then we fail to capture the full potential of this exceptional tipping point in cannabis we’re facing in Michigan and across the country. That’s why we didn’t begin any production or deep operational planning until we had a very intimate understanding of people’s stories and their unique physical, mental, wellness, and creative needs.”
The company says it is aggressively deploying lean business management philosophy across all core value streams to deliver the highest quality products by driving operational efficiency, reducing costs, and designing each core service exactly to customer needs. The cultivation and processing facilities also meet current good manufacturing practice standards, ensuring products are safely produced and handled according to consistent quality measurements that meet food and drug standards.